Is Autonomix Medical, Stock a Good Investment?
Autonomix Medical, Investment Advice | AMIX |
- Examine Autonomix Medical,'s financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Autonomix Medical,'s leadership team and their track record. Good management can help Autonomix Medical, navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Autonomix Medical,'s business and its evolving consumer preferences.
- Compare Autonomix Medical,'s performance and market position to its competitors. Analyze how Autonomix Medical, is positioned in terms of product offerings, innovation, and market share.
- Check if Autonomix Medical, pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Autonomix Medical,'s stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Autonomix Medical, Common stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Autonomix Medical, Common is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Autonomix Medical, Stock
Researching Autonomix Medical,'s stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 27.0% of the company shares are held by company insiders. The book value of Autonomix Medical, was presently reported as 3.21. The company recorded a loss per share of 19.74. Autonomix Medical, Common had not issued any dividends in recent years. The entity had 1:20 split on the 25th of October 2024.
To determine if Autonomix Medical, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Autonomix Medical,'s research are outlined below:
| Autonomix Medical, generated a negative expected return over the last 90 days | |
| Autonomix Medical, has high historical volatility and very poor performance | |
| Autonomix Medical, has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (15.43 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Autonomix Medical, generates negative cash flow from operations | |
| Autonomix Medical, has a poor financial position based on the latest SEC disclosures | |
| About 27.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Autonomix Medical, Inc. Announces Closing of 10. ... |
Autonomix Medical, Quarterly Long Term Debt |
|
Autonomix Medical,'s market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.92 M.Market Cap |
|
Autonomix Medical,'s profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.64) | (1.72) | |
| Return On Capital Employed | (0.87) | (0.91) | |
| Return On Assets | (1.64) | (1.72) | |
| Return On Equity | (2.02) | (2.12) |
Determining Autonomix Medical,'s profitability involves analyzing its financial statements and using various financial metrics to determine if Autonomix Medical, is a good buy. For example, gross profit margin measures Autonomix Medical,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Autonomix Medical,'s profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Autonomix Medical,'s accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Autonomix Medical, Common. Check Autonomix Medical,'s Beneish M Score to see the likelihood of Autonomix Medical,'s management manipulating its earnings.
Basic technical analysis of Autonomix Stock
As of the 4th of December, Autonomix Medical, shows the Standard Deviation of 13.55, mean deviation of 7.36, and Risk Adjusted Performance of (0.04). Autonomix Medical, Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Autonomix Medical,'s insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Autonomix Medical, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Autonomix Medical,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Autonomix Medical, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Smith Trent N. over two months ago Disposition of tradable shares by Smith Trent N. of Autonomix Medical, subject to Rule 16b-3 | ||
Smith Trent N over six months ago Autonomix Medical exotic insider transaction detected | ||
Lori Bisson over six months ago Autonomix Medical, exotic insider transaction detected |
Understand Autonomix Medical,'s technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Autonomix Medical,'s various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | 2.15 | |||
| Mean Deviation | 7.36 | |||
| Coefficient Of Variation | (1,513) | |||
| Standard Deviation | 13.55 | |||
| Variance | 183.59 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.86) | |||
| Total Risk Alpha | (2.74) | |||
| Treynor Ratio | 2.14 | |||
| Maximum Drawdown | 114.12 | |||
| Value At Risk | (15.75) | |||
| Potential Upside | 21.84 | |||
| Skewness | 0.9994 | |||
| Kurtosis | 9.89 |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | 2.15 | |||
| Mean Deviation | 7.36 | |||
| Coefficient Of Variation | (1,513) | |||
| Standard Deviation | 13.55 | |||
| Variance | 183.59 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.86) | |||
| Total Risk Alpha | (2.74) | |||
| Treynor Ratio | 2.14 | |||
| Maximum Drawdown | 114.12 | |||
| Value At Risk | (15.75) | |||
| Potential Upside | 21.84 | |||
| Skewness | 0.9994 | |||
| Kurtosis | 9.89 |
Consider Autonomix Medical,'s intraday indicators
Autonomix Medical, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Autonomix Medical, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Autonomix Medical, time-series forecasting models is one of many Autonomix Medical,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Autonomix Medical,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Autonomix Stock media impact
Far too much social signal, news, headlines, and media speculation about Autonomix Medical, that are available to investors today. That information is available publicly through Autonomix media outlets and privately through word of mouth or via Autonomix internal channels. However, regardless of the origin, that massive amount of Autonomix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Autonomix Medical, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Autonomix Medical, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Autonomix Medical,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Autonomix Medical, alpha.
Autonomix Medical, Corporate Executives
Elected by the shareholders, the Autonomix Medical,'s board of directors comprises two types of representatives: Autonomix Medical, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Autonomix. The board's role is to monitor Autonomix Medical,'s management team and ensure that shareholders' interests are well served. Autonomix Medical,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Autonomix Medical,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert MD | CoFounder Officer | Profile | |
| Landy Toth | CoFounder Officer | Profile |
Already Invested in Autonomix Medical, Common?
The danger of trading Autonomix Medical, Common is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Autonomix Medical, is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Autonomix Medical,. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Autonomix Medical, Common is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.